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Facilitation of spinal NMDA receptor currents by spillover of
synaptically released glycine
Abstract
In the mammalian CNS, N-methyl-D-aspartate (NMDA) receptors serve prominent roles in many
physiological and pathophysiological processes including pain transmission. For full activation, NMDA
receptors require the binding of glycine. It is not known whether the brain uses changes in extracellular
glycine to modulate synaptic NMDA responses. Here, we show that synaptically released glycine
facilitates NMDA receptor currents in the superficial dorsal horn, an area critically involved in pain
processing. During high presynaptic activity, glycine released from inhibitory interneurons escapes the
synaptic cleft and reaches nearby NMDA receptors by so-called spillover. In vivo, this process may
contribute to the development of inflammatory hyperalgesia.
well as the cytosolic protein GFP, to the AIS.
However, additional motifs probably play a
role in establishing the differential distribu-
tion of certain types of sodium channel in
vivo. We also obtained evidence for the as-
sociation of ankyrin G with the motif we have
identified. From a mechanistic point of view,
ankyrin G could be primarily involved in
anchoring sodium channels at the plasma
membrane. However, we cannot exclude the
possibility that the two partners could be
preassembled early in biogenesis and cotrans-
ported during sorting, as observed in the case
of presynaptic proteins (29, 30).
Note added in proof: During revision of
this report, Lemaillet et al. (31) identified a
conserved ankyrin-binding motif located
within the AIS motif.
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Facilitation of Spinal NMDA
Receptor Currents by Spillover of
Synaptically Released Glycine
Seifollah Ahmadi,1* Uta Muth-Selbach,2* Andreas Lauterbach,1*
Peter Lipfert,2 Winfried L. Neuhuber,3 Hanns Ulrich Zeilhofer1†
In the mammalian CNS, N-methyl-D-aspartate (NMDA) receptors serve prom-
inent roles in many physiological and pathophysiological processes including
pain transmission. For full activation, NMDA receptors require the binding of
glycine. It is not known whether the brain uses changes in extracellular glycine
to modulate synaptic NMDA responses. Here, we show that synaptically re-
leased glycine facilitates NMDA receptor currents in the superﬁcial dorsal horn,
an area critically involved in pain processing. During high presynaptic activity,
glycine released from inhibitory interneurons escapes the synaptic cleft and
reaches nearby NMDA receptors by so-called spillover. In vivo, this process may
contribute to the development of inﬂammatory hyperalgesia.
Glycine serves a dual role in central neurotrans-
mission. It is not only the primary inhibitory
neurotransmitter in the spinal cord and brain
stem, but also an obligatory coagonist at excita-
tory glutamate receptors of the NMDA type
(1–3). Although glycine concentrations in the
cerebrospinal fluid are in the micromolar range
(4–6), which would fully activate this site (7),
glycine transporters located on glial cells can
lower extracellular glycine in the vicinity of
synaptic NMDA receptors to subsaturating
concentrations (8–10). A physiological role of
glycine in the modulation of NMDA receptor–
mediated synaptic transmission therefore ap-
pears possible. We have previously shown that
in the spinal cord dorsal horn the neuropeptide
nocistatin (NST) (11) specifically inhibits the
synaptic release of glycine [and -aminobutyric
acid (GABA)] without affecting the release of
L-glutamate (12). We have now used this pep-
tide to show that spinal NMDA receptors can be
facilitated by spillover of synaptically released
glycine both in spinal cord slices and in vivo.
Glutamatergic and glycinergic input was ac-
tivated simultaneously by electrical field stim-
ulation. Excitatory and inhibitory postsynaptic
currents (EPSCs and IPSCs) were isolated
pharmacologically and recorded from superfi-
cial dorsal horn neurons in transverse rat
spinal cord slices (13). At a saturating con-
centration of 10 M (12), NST reversibly
reduced the amplitude of glycinergic IPSCs
(gly-IPCSs) by 36.5  7.2% (n  15, P 
0.01, paired t test). By contrast, -amino-3-
hydroxy-5-methylisoxazole-4-propionic acid
(AMPA) receptor–mediated EPSCs (AMPA-
EPSCs) remained completely unchanged
[96.7  4.3% of control amplitudes, n  11,
P  0.33, see also (12)], whereas NMDA-
EPSCs were reversibly reduced by 29.2 
3.2% (P  0.001) in 15 out of 17 neurons
(Fig. 1A).
Inhibition of NMDA-EPSCs was complete-
ly prevented when the slices were continuously
superfused with glycine (100 M) to perma-
nently saturate NMDA receptors ( NMDA-
EPSC: 0.16 5.9%, n 6, P 0.67, ANOVA
followed by Scheffe´’s post hoc test). A signif-
icant contribution of GABA acting on iono-
tropic GABAA or G protein–coupled GABAB
receptors could be excluded, because all
experiments were performed in the contin-
uous presence of the GABAA receptor
blocker bicuculline (10 M) and additional
application of the GABAB receptor antag-
onist CGP55845 (100 M) did not prevent
inhibition ( NMDA-EPSC: 37.2  10.2%,
n  8, P  0.01) (Fig. 1B).
A reduction in glycine release could inter-
fere with NMDA receptor–mediated synaptic
transmission by at least two mechanisms.
First, glycine might act through presynaptic
strychnine-sensitive glycine receptors to fa-
cilitate the release of glutamate, an action that
has been demonstrated in the brainstem (14).
A significant contribution of this process to
the inhibition of NMDA-EPSCs described
here appears unlikely, because NMDA-
EPSCs were recorded in the presence of
strychnine (300 nM). Second, glycine might
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act postsynaptically by activating the glycine
binding site of NMDA receptors. To prove
this hypothesis, we used D-serine, another
agonist at the glycine binding site of
NMDA receptors (15, 16), which is ineffec-
tive at strychnine-sensitive glycine receptors.
Superfusion of the slices with D-serine (100
M) completely prevented inhibition of
NMDA-EPSCs ( NMDA-EPSC: –1.9 
4.0%, n  9, P  0.47), whereas L-serine
was ineffective ( NMDA-EPSC: –60.0 
6.6%, n  8, P  0.01) (Fig. 1C).
Results obtained with D-serine also argue
against the possibility that glycine directly acti-
vated particular subtypes of NMDA receptors
containing NR3A or NR3B subunits, which are
activated by glycine in the absence of glutamate,
but blocked by D-serine (17). D-Serine did not
inhibit NMDA-EPSCs in our experiments (
NMDA-EPSC: –3.3  5.8%, n  4; P  0.39,
four presynaptic stimuli). A direct glycine-
independent effect of NST on NMDA or glycine
receptors could also be excluded, because NST
did not inhibit membrane currents evoked by
exogenous NMDA or glycine [fig. S1 and (12)].
Glycinergic interneurons could either form
direct synaptic contacts with postsynaptic
NMDA receptors or, alternatively, synaptically
released glycine could diffuse out of the synaptic
cleft of glycinergic synapses and could reach
 
Fig. 1. NST-mediated inhibition of gly-IPSCs and NMDA-EPSCs. (A) (Top)
Averages of ten consecutive current traces recorded under control con-
ditions, in the presence of NST (10 M) and after its removal. (Bottom)
Time course of inhibition (means  SEM). AMPA-EPSCs (, n  11) and
NMDA-EPSCs (red circles, n  15) and gly-IPSCs (, n  15). (B)
NST-mediated inhibition of NMDA-EPSCs was prevented by continuous
superfusion of slices with glycine (100 M, n  6), but not with the
GABAB receptor antagonist CGP55845 (100 M, n  8). (C) D-Serine
(100 M) mimicked the effect of glycine (n  9). L-Serine (100 M) was
without effect (n  8). Recordings shown in (A) were made at room
temperature (20°C) and after a single synaptic stimulation, (B and C)
were done at 35°C and after four synaptic stimulations at 500Hz.
Fig. 2. Inhibition of NMDA-EPSCs by NST is due to reduced glycine
spillover. NMDA-EPSC inhibition depended on the number of presynaptic
stimuli (A) and on the recording temperature (B). Left, averaged current
responses; middle, statistical analysis; and right, time course (for six, ﬁve,
and eight cells for one, two, and four stimuli; for ﬁve, ﬁve, and six cells,
for recording temperatures of 20°C, 27°C, and 35°C, respectively).
R E P O R T S
www.sciencemag.org SCIENCE VOL 300 27 JUNE 2003 2095
nearby NMDA receptors through diffusion, a
process called spillover (1, 18, 19). Inhibition of
NMDA-EPSCs by NST exhibited two character-
istic features of spillover (19, 20). Inhibition
increased with decreasing recording tempera-
tures and with an increased amount of glycine
released (Fig. 2). At a near-physiological tem-
perature of 35°C and when four presynaptic
stimulations were applied, inhibition was 43.4
3.3% (n 8, P 0.01), which is similar to what
was obtained after a single stimulus at 20°C
(41.5  2.0%, n  5). However, when a single
stimulus was applied at 35°C, inhibition was
reduced to 10.6  3.4% (n  5). These results
indicate that synaptically released glycine
reached NMDA receptors after it had diffused
over a certain distance where it was partially
taken up by temperature-sensitive glycine trans-
porters (21), which at physiological temperatures
limit the diffusion of glycine. However, under
conditions of repeated presynaptic stimulation,
synaptically released glycine can apparently
overwhelm these transporters to facilitate synap-
tic NMDA receptors. The modulation of
NMDA-EPSCs by NST also demonstrates that
glycine binding to NMDA receptors is not satu-
rated under resting conditions [see also (22)].
Indeed, when a pure glutamatergic input was
activated by dorsal root stimulation, D-serine
(100 M) potentiated NMDA-EPSCs by 55.4
11.0% (n  6, P  0.024, fig. S2), which
suggests that resting glycine was near the median
effective concentration (EC50).
Fig. 3. Effects of NST on
gly-IPSCs and NMDA-
EPSCs in the dorsal versus
ventral horn. (A) Biocytin-
labeled neurons in the su-
perﬁcial layers of the dor-
sal horn (top) and in the
ventral horn, where re-
cordings were made from
large diameter presumed
motor neurons (bottom).
Scale bars, 20 m (dorsal
horn) and 40 m (ventral
horn). (B) Averaged cur-
rent responses in the
dorsal (top) and ventral
horn (bottom). (C) Loca-
tions of the recorded neu-
rons, , gly-IPSCs, ,
NMDA-EPSCs. (D) Statisti-
cal analysis. **P  0.01,
paired t test, dorsal horn,
n  18 and 19, NMDA-
EPSCs and gly-IPSCs, re-
spectively. Ventral horn,
n 5 and 9, NMDA-EPSCs
and gly-IPSCs, respectively.
Recordings were made at
35°C, after a single synaptic stimulus (gly-IPSCs) or after four stimuli (NMDA-EPSCs).
Fig. 4. Dose-dependent effects of NST on pain-related behavior in the rat
formalin test. (A) Number of ﬂinches per minute (means SEM) of rats treated
with different doses of NST injected intrathecally versus time: 10 nmol (),1
nmol ( ), 100 pmol (‚), 10 pmol (ƒ), 1 pmol ({), 100 fmol (), vehicle ().
(B) Dose-response relationship for phase I (1 to 10 min, ) and phase II (21 to
60 min, ). Values (means  SEM) normalized to vehicle-treated animals. (C)
Total number of ﬂinches (means  SEM) in rats injected with either 10 nmol or
1 pmol of NST or vehicle () and pretreated with ACSF, D-serine, or L-serine
(each 100 g). (D) Same as (C), but treated with vehicle or MK-801 (10 g) and
pretreated with D-serine (100 g). (E) Motor performance of rats (rounds per
minute ) before (x axis) and after (y axis) treatment with 10 nmol () or 1 pmol
({) NST, MK-801 (10 g) ( ), or vehicle (). Each symbol represents an
individual animal. (F) Statistical analysis (means SEM). *P 0.05; **P 0.01;
***P  0.001; ns, not signiﬁcant (ANOVA followed by Scheffe´’s post hoc test).
n  6 rats/group.
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We tested whether NST inhibited glyciner-
gic IPSCs and/or NMDA-EPSCs differently in
different regions of the spinal cord. Inhibition of
NMDA-EPSCs by NST was absent in the ven-
tral horn, the site of spinal motor control (Fig.
3). Because NST was inactive also at ventral
horn gly-IPSCs, this finding most likely reflects
the lack of expression of NST receptors in the
ventral horn and does not contradict the exis-
tence of glycine spillover in this region (23).
Spillover of a fast neurotransmitter to
extrasynaptic receptors or receptors located
in neighboring synapses has been reported
previously (24 ). However, its significance
for in vivo synaptic processing has re-
mained elusive.
When NST is injected intrathecally, it mod-
ulates spinal pain processing (11, 12). We test-
ed NST in the rat formalin test, an animal
model of tonic pain (13). Low (picomolar)
doses of NST were antinociceptive, whereas
higher (nanomolar) doses were pronociceptive
(Fig. 4, A and B). At 10 nmol, NST increased
the average number of flinches per minute to
173.9% and 159.8% of control in phase I (1 to
10 min) and II (21 to 60 min) of the formalin
test, respectively (P 0.001 and P 0.01, n
6 each). The lower dose of 1 pmol NST signif-
icantly reduced the number of flinches per
minute to 55.1% and 49.3% (P 0.05 and P
0.01) in phase I and II, respectively. The reduc-
tion by NST of inhibitory neurotransmission
probably underlies its pronociceptive effect
(12). To test whether a reduced availability of
glycine at NMDA receptors underlies the an-
tinociceptive effect, we pretreated rats intrathe-
cally with D-serine and, as a negative control,
with L-serine (each 100 g). Antinociception
evoked by 1 pmol NST was selectively blocked
by D-serine, whereas the pronociceptive effect
of the higher dose (10 nmol) remained virtually
unchanged in rats treated with either D- or
L-serine (Fig. 4C). By contrast, analgesia in-
duced with MK-801 (10 g), an open channel
blocker of NMDA receptors, was unaffected by
D-serine (Fig. 4D). D-serine (and L-serine) per
se had no significant effect in the formalin test
(Fig. 4C), which suggests that glycine binding
sites were saturated during intense nociceptive
stimulation.
The use of NMDA receptor blockers as
therapeutic agents has been hampered by their
inhibitory effects in CNS areas other than the
spinal cord dorsal horn, where they give rise to
severe side effects (25, 26). Because the syn-
aptic effects of NST were limited to the sensory
(dorsal) part of the spinal cord, we tested
whether inhibition of NMDA receptor–
mediated neurotransmission by NST would
spare motor function (13). Neither the high
dose (10 nmol) nor the low dose (1 pmol) of
NST impaired motor performance in the ro-
tarod test (Fig. 4, E and F). Unlike NST, MK-
801 (10 g) significantly reduced the rotarod
performance (Fig. 4F).
Our finding that glycine released from inhib-
itory interneurons not only mediates synaptic
inhibition, but also contributes to the facilitation
of NMDA receptors adds to the emerging role
of glycine as an excitatory neurotransmitter (14,
17). During acute pain states, when glycinergic
interneurons in the spinal cord dorsal horn are
excessively activated, glycine can escape the
synaptic cleft and reach nearby NMDA recep-
tors. This spillover causes NMDA receptor fa-
cilitation, which apparently contributes to the
excessive activation of NMDA receptors, which
is thought to underlie the development of chron-
ic pain (27). Furthermore, the finding that a
suppression of this process induces analgesia
reveals that spillover of a fast neurotrans-
mitter in the CNS can indeed occur in vivo. A
selective inhibition of this process in the dor-
sal horn may provide a new and promising
strategy for the prevention of chronic pain.
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Comprehensive Identiﬁcation of
Human bZIP Interactions with
Coiled-Coil Arrays
John R. S. Newman* and Amy E. Keating†
In eukaryotes, the combinatorial association of sequence-speciﬁc DNA binding
proteins is essential for transcription. We have used protein arrays to test 492
pairings of a nearly complete set of coiled-coil strands from human basic-region
leucine zipper (bZIP) transcription factors. We ﬁnd considerable partnering selec-
tivity despite the bZIPs’ homologous sequences. The interaction data are of high
quality, as assessed by their reproducibility, reciprocity, and agreement with pre-
vious observations. Biophysical studies in solution support the relative binding
strengths observed with the arrays. New associations provide insights into the
circadian clock and the unfolded protein response.
In DNA binding transcription factors, autono-
mously folding domains are often responsible
for the formation of homo- and heterodimeric
protein complexes. Transcription factor dimer-
ization can increase the selectivity of protein-
DNA interactions and generate a large amount
of DNA binding diversity from a relatively
small number of proteins (1, 2). Dimerization
also leads to the establishment of complex reg-
ulatory networks (3), and dimers can interact
with other proteins required for transcription
(4). The bZIP transcription factors constitute an
important class of eukaryotic DNA binding pro-
teins in which dimerization has been shown to
occur by way of coiled-coil regions. Although
previous studies have described bZIP pairings
and the biological effects of these associations
(3, 5–9), many substantive questions remain
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